Goodbody Health Inc
Change company Symbol lookup
Select an option...
SCNNF Goodbody Health Inc
VTRS Viatris Inc
JPM JPMorgan Chase & Co
RXDX Prometheus Biosciences Inc
UHAL Amerco
BRK.B Berkshire Hathaway Inc
NTRA Natera Inc
JJPFF iPath? Bloomberg Precious Metals Subindex Total Return(SM) ETN
WCC Wesco International Inc
EZOO Ezagoo Ltd
Go


Based in Canada
Company profile

Goodbody Health Inc, formerly Sativa Wellness Group Inc., is a Canada-based wellness company. The Company operates both in wellness testing in the United Kingdom and as a vertically integrated cannabinoid (CBD) company that operates in the United Kingdom and the European Union. It operates under one segment: the sale of cannabinoid products and clinic and cannabinoid testing. The Company focuses on offering COVID and blood testing clinics, CBD extraction, wholesale bulk isolate and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs. It provides a local level network of approximately 140 clinics, providing over 30 blood and polymerase chain reaction (PCR) tests for at home or in clinic testing. The Company’s subsidiaries include Borganic, Olimax, Olimax RE, Sativa Wellness Group Poland, Sativa Group, Goodbody Botanicals and Phytovista Laboratories.

Closing Price
$0.0606
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.0606
Day's Low
0.045
Volume
(Heavy Day)
Volume:
16,800

10-day average volume:
36,781
16,800

Company Profile

Goodbody Health Inc, formerly Sativa Wellness Group Inc., is a Canada-based wellness company. The Company operates both in wellness testing in the United Kingdom and as a vertically integrated cannabinoid (CBD) company that operates in the United Kingdom and the European Union. It operates under one segment: the sale of cannabinoid products and clinic and cannabinoid testing. The Company focuses on offering COVID and blood testing clinics, CBD extraction, wholesale bulk isolate and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs. It provides a local level network of approximately 140 clinics, providing over 30 blood and polymerase chain reaction (PCR) tests for at home or in clinic testing. The Company’s subsidiaries include Borganic, Olimax, Olimax RE, Sativa Wellness Group Poland, Sativa Group, Goodbody Botanicals and Phytovista Laboratories.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
--
Price/Book (MRQ)
2.00x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

No historic growth available.

Short Interest

No short interest available.

Share Information

SCNNF is in a share class of common stock
Float
264.1M
Shares Outstanding
365.0M
Institutions Holding Shares
2
0.45%

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

No company officers listed.

Address

Insider Trading

No insider trading activity.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.